Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 4, 1997

View Archived Issues

Company Profile: PharmaPrint

Geron: Q3 1997 highlights

Integra LifeSciences: Q3 1997 highlights

Acacia Biosciences receives SBIR grant for drug discovery research

Maxim reports promising data from AML trial with Maxamine

Miravant reports promising interim phase III results for breast cancer trial

Single injections of RC-3095 produce prolonged reductions in EGF receptor number and expression

Ligand: Q3 1997 highlights

Antiviral thiazolidines and thiazolidinones from INSERM

Diagnostic use of specific sigma2 ligands described by Wake Forest University

MDR modulators prepared at Janssen

Bayer develops CETP inhibitors

Vitronectin receptor antagonists described by Hoechst

Method of inactivating RNA viruses offered for licensing

Actinomycin D: new use in AIDS therapy available for licensing

New inhibitor of inflammatory bone resorption presented at Tokyo congress

New glucocorticoid from Kissei under development for asthma

S-2474: antiarthritic agent with dual NSAID/DMARD profile

Agouron, Roche terminate cancer collaboration; AG-337 development discontinued

Results of IDEC-151/SB-217969 phase I trial reported

NeoTherapeutics' cognition enhancer in preclinical testing

Plant-derived biflavonoid with antiinflammatory activity

Active principle of herbal medicine with immunomodulating effects

Abecarnil reverses benzodiazepine resistance in mice

Plant extract with both antiinflammatory and antihistaminic activity

New mechanism involved in the anxiolytic effect of flesinoxan?

Sanofi in-licenses antidiabetic drug from Bayer

Fareston launched in U.S. for metastatic breast cancer

Profile of an mGluR2/mGluR3 agonist

New antipsychotic reported in development at Merck KGaA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...